Frank Daniel Mersebach

Frank Daniel Mersebach has extensive experience in the pharmaceutical industry, currently serving as Vice President of Early Portfolio & Insights at Novo Nordisk since January 2016, where responsibilities include leading the commercial direction for the drug portfolio in Other Serious Chronic Diseases. Previous roles at Novo Nordisk include Vice President of Commercial Planning for Cardiovascular disease and Other Serious Chronic Diseases, Global Competitive Intelligence Vice President, and various directorial and managerial positions. Frank's career began with roles in research and development and quality assurance, advancing through management positions focused on investor relations and global product management. Educational credentials include an MSc in Mechanical Engineering from Aalborg University and an ECPM in Pharmaceutical Medicine from the University of Basel.